Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial
Craig M. McDonald(University of California Davis Medical Center), Laura Brown, Catherine Braun, Mark S. Awadalla(Capricor Therapeutics (United States)), Erik Henricson(UC Davis Health), Chamindra G. Laverty(University of California San Diego), Jonathan H. Soslow(Vanderbilt University Medical Center), Eduardo Marbán(Cedars-Sinai Smidt Heart Institute), Susan T. Iannaccone(Scottish Rite Hospital), Nancy Bass(Children's Hospital of Wisconsin), Scott Batchelor, Aravindhan Veerapandiyan(Arkansas Children's Hospital), Russell J. Butterfield(University of Utah), Seth J. Perlman(Seattle Children's Hospital), Kristi Elliott(Capricor Therapeutics (United States)), Alyssa Boudreau, Leigh Ramos‐Platt, Edward C. Smith(Duke Institute for Health Innovation), Kan N. Hor(Nationwide Children's Hospital), William Alton, Rebecca J. Scharf(University of Virginia Children's Hospital), Cuixia Tian(Cincinnati Children's Hospital Medical Center), H. Phan(Rare Disease Therapeutics (United States)), Kelsey Bloom, Chet Villa(Cincinnati Children's Hospital Medical Center), Michael Taylor(Children's National), S Apkon(Children's Hospital Colorado), Katheryn Gambetta(Lurie Children's Hospital), Michael Binks(Capricor Therapeutics (United States)), Linda Marban(Capricor Therapeutics (United States)), Kathryn mosher(Akron Children's Hospital), Katherine D Mathews(University of Iowa), Michelle Brown, Nathaniel Hogan(Capricor Therapeutics (United States)), Kaitlin Batley, Madeline Brown, Margot Amalachandran, Pallavi Anand, Martha Arellano-Garcia, Partha S Ghosh(Boston Children's Hospital), RJ Billena, James Signorovich(Analysis Group (United States)), Eugenio Mercuri(Università Cattolica del Sacro Cuore), Kelly Bonarrigo, Saunder M Bernes(Phoenix Children's Hospital), Kevin C Berth(Capricor Therapeutics (United States)), Kati Maharry(Capricor Therapeutics (United States)), Jane A. Emerson(University of Missouri), Meghan Bochnak, Arun S. Varadhachary(Temple University)
Cited by 0
Related Papers
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
|The Lancet Neurology|2009|2k
Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care
|The Lancet Neurology|2009|1.2k
Nusinersen initiated in infants during the presymptomatic stage of spinal muscular atrophy: Interim efficacy and safety results from the Phase 2 NURTURE study
|Neuromuscular Disorders|2019|636
Mutations in the skeletal muscle α-actin gene in patients with actin myopathy and nemaline myopathy
|Nature Genetics|1999|401